Compare ASTI & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASTI | CTSO |
|---|---|---|
| Founded | 2005 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.6M | 23.9M |
| IPO Year | 2014 | 2008 |
| Metric | ASTI | CTSO |
|---|---|---|
| Price | $3.57 | $0.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $20.00 | $5.38 |
| AVG Volume (30 Days) | ★ 323.7K | 55.8K |
| Earning Date | 05-11-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 70.23 | 65.79 |
| EPS | N/A | ★ N/A |
| Revenue | $10,398,149.00 | ★ $22,503,908.00 |
| Revenue This Year | N/A | $10.34 |
| Revenue Next Year | N/A | $22.41 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 163.25 | 48.53 |
| 52 Week Low | $1.40 | $0.35 |
| 52 Week High | $9.87 | $1.22 |
| Indicator | ASTI | CTSO |
|---|---|---|
| Relative Strength Index (RSI) | 40.54 | 48.44 |
| Support Level | $2.90 | $0.36 |
| Resistance Level | $4.68 | $0.40 |
| Average True Range (ATR) | 0.28 | 0.02 |
| MACD | 0.08 | 0.00 |
| Stochastic Oscillator | 53.41 | 58.94 |
Ascent Solar Technologies Inc is a solar technology company that manufactures and sells photovoltaic (PV) solar modules that are flexible, durable, and possess attractive power to weight and power to area performance. Its technology provides renewable power solutions to high-value production and specialty solar markets where traditional rigid solar panels are not suitable, including space power beaming, aerospace, satellites, near earth orbiting vehicles, fixed wing unmanned aerial vehicles (UAV), aquatic, terrestrial, and other weight-sensitive markets with transformational high quality, value added product applications. It operates in single PV segment that sells PV products and engineering services and currently, is selling it in North America.
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.